Hester Biosciences Dirección
Dirección controles de criterios 3/4
El CEO de Hester Biosciences es Rajiv Gandhi , nombrado en Mar 2005, tiene una permanencia de 19.67 años. compensación anual total es ₹37.07M, compuesta por 51.4% salario y 48.6% primas, incluidas acciones y opciones de la empresa. posee directamente un 10.47% de las acciones de la empresa, por valor de ₹2.37B. La antigüedad media del equipo directivo y de la junta directiva es de 3.6 años y 4.6 años, respectivamente.
Información clave
Rajiv Gandhi
Chief Executive Officer (CEO)
₹37.1m
Compensación total
Porcentaje del salario del CEO | 51.4% |
Permanencia del CEO | 19.7yrs |
Participación del CEO | 10.5% |
Permanencia media de la dirección | 3.6yrs |
Promedio de permanencia en la Junta Directiva | 4.6yrs |
Actualizaciones recientes de la dirección
Hester Biosciences Limited's (NSE:HESTERBIO) CEO Compensation Looks Acceptable To Us And Here's Why
Aug 23Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Jan 11How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?
Aug 07Recent updates
Hester Biosciences Limited's (NSE:HESTERBIO) CEO Compensation Looks Acceptable To Us And Here's Why
Aug 23What Hester Biosciences Limited's (NSE:HESTERBIO) 26% Share Price Gain Is Not Telling You
Jul 27Revenues Working Against Hester Biosciences Limited's (NSE:HESTERBIO) Share Price
Jun 12Hester Biosciences (NSE:HESTERBIO) Has Announced A Dividend Of ₹10.00
Aug 01Would Hester Biosciences Limited (NSE:HESTERBIO) Be Valuable To Income Investors?
Mar 03Did You Miss Hester Biosciences' (NSE:HESTERBIO) Whopping 308% Share Price Gain?
Feb 13What Is The Ownership Structure Like For Hester Biosciences Limited (NSE:HESTERBIO)?
Jan 26Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Jan 11Hester Biosciences Limited's (NSE:HESTERBIO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 25Are Hester Biosciences's (NSE:HESTERBIO) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 10These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Nov 25How Does Hester Biosciences Limited (NSE:HESTERBIO) Fare As A Dividend Stock?
Nov 10If You Had Bought Hester Biosciences (NSE:HESTERBIO) Shares Five Years Ago You'd Have Earned 212% Returns
Oct 26What Type Of Shareholders Own The Most Number of Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Oct 05Are Strong Financial Prospects The Force That Is Driving The Momentum In Hester Biosciences Limited's NSE:HESTERBIO) Stock?
Sep 14These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Aug 25How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?
Aug 07Hester Biosciences Limited (NSE:HESTERBIO) Is Yielding 0.5% - But Is It A Buy?
Jul 07Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Sep 30 2024 | n/a | n/a | ₹235m |
Jun 30 2024 | n/a | n/a | ₹194m |
Mar 31 2024 | ₹37m | ₹19m | ₹189m |
Dec 31 2023 | n/a | n/a | ₹185m |
Sep 30 2023 | n/a | n/a | ₹257m |
Jun 30 2023 | n/a | n/a | ₹285m |
Mar 31 2023 | ₹41m | ₹19m | ₹266m |
Dec 31 2022 | n/a | n/a | ₹298m |
Sep 30 2022 | n/a | n/a | ₹271m |
Jun 30 2022 | n/a | n/a | ₹308m |
Mar 31 2022 | ₹48m | ₹20m | ₹393m |
Dec 31 2021 | n/a | n/a | ₹413m |
Sep 30 2021 | n/a | n/a | ₹451m |
Jun 30 2021 | n/a | n/a | ₹412m |
Mar 31 2021 | ₹52m | n/a | ₹344m |
Dec 31 2020 | n/a | n/a | ₹275m |
Sep 30 2020 | n/a | n/a | ₹267m |
Jun 30 2020 | n/a | n/a | ₹265m |
Mar 31 2020 | ₹39m | n/a | ₹292m |
Dec 31 2019 | n/a | n/a | ₹396m |
Sep 30 2019 | n/a | n/a | ₹409m |
Jun 30 2019 | n/a | n/a | ₹413m |
Mar 31 2019 | ₹21m | ₹20m | ₹416m |
Mar 31 2018 | ₹24m | ₹19m | ₹256m |
Compensación vs. Mercado: La compensación total de Rajiv($USD439.69K) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD196.14K).
Compensación vs. Ingresos: La compensación de Rajiv ha sido consistente con los resultados de la empresa en el último año.
CEO
Rajiv Gandhi (62 yo)
19.7yrs
Permanencia
₹37,070,000
Compensación
Mr. Rajiv Dinesh Gandhi serves as Independent Director for Steelcast Limited since January 23, 2023. Mr. Gandhi joined the Steelcast Limited on January 23, 2023. He has been the Executive Chief Executive O...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Executive CEO | 19.7yrs | ₹37.07m | 10.47% ₹ 2.4b | |
Executive Director | no data | ₹5.40m | sin datos | |
Chief Financial Officer | no data | sin datos | sin datos | |
Senior VP of Sales & Marketing and COO | less than a year | sin datos | sin datos | |
Company Secretary & Compliance Officer | 6.5yrs | sin datos | sin datos | |
CEO of Hester Biosciences Nepal Private Limited | no data | sin datos | sin datos | |
Consultant | no data | sin datos | sin datos |
3.6yrs
Permanencia media
62yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de HESTERBIO se considera experimentado (3.6 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Executive CEO | 37.6yrs | ₹37.07m | 10.47% ₹ 2.4b | |
Executive Director | 3.1yrs | ₹5.40m | sin datos | |
Non-Executive Non-Independent Chairman | 31.9yrs | ₹250.00k | 4.69% ₹ 1.1b | |
Non-Executive & Non-Independent Director | 25.6yrs | sin datos | 4.74% ₹ 1.1b | |
Non Executive Non Independent Director | 37.6yrs | ₹270.00k | 8.2% ₹ 1.9b | |
Non-Executive Independent Director | 3.1yrs | ₹150.00k | sin datos | |
Alternate Director | 8.5yrs | ₹150.00k | 8.19% ₹ 1.9b | |
Non-Executive Independent Director | 4.6yrs | ₹480.00k | sin datos | |
Non-Executive Independent Director | 4.6yrs | ₹500.00k | sin datos | |
Non-Executive & Independent Director | 1.4yrs | ₹150.00k | sin datos | |
Non-Executive & Independent Director | 1.4yrs | ₹100.00k | sin datos |
4.6yrs
Permanencia media
58.5yo
Promedio de edad
Junta con experiencia: La junta directiva de HESTERBIO se considera experimentada (4.6 años de antigüedad promedio).